Cargando…
Menstruation, anticoagulation, and contraception: VTE and uterine bleeding
Abnormal or excessive menstrual bleeding affects one‐third of reproductive‐aged women. This number increases to 70% among women on direct oral anticoagulants (DOACs). While there is some variation in frequency of heavy menstrual bleeding (HMB) with different DOAC options, all menstruating individual...
Autores principales: | Samuelson Bannow, Bethany, McLintock, Claire, James, Paula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326079/ https://www.ncbi.nlm.nih.gov/pubmed/34368613 http://dx.doi.org/10.1002/rth2.12570 |
Ejemplares similares
-
Are outpatient anticoagulation management services the wave of the future (again)?
por: Samuelson Bannow, Bethany
Publicado: (2022) -
How I approach bleeding in hospitalized patients
por: Bannow, Bethany Samuelson, et al.
Publicado: (2023) -
An illustrated review of bleeding assessment tools and common coagulation tests
por: Elbaz, Carolyne, et al.
Publicado: (2020) -
Menstrual Technology Innovations and the Implications for Heavy Menstrual Bleeding
por: Liberty, Abigail, et al.
Publicado: (2023) -
Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review
por: van der Wall, Sake J., et al.
Publicado: (2018)